All News HANDOK Inc.

Equities

A002390

KR7002390003

End-of-day quote Korea S.E. Other stock markets 03:30:00 03/06/2024 am IST			5-day change	1st Jan Change
15,800 ^KRW	+1.41%		-5.22%	+10.49%

24/05	Biocon Ties Up with Handok to Market Anti-Diabetic Drug Liraglutide in South Korea	MT
24/05	Biocon Limited Signs Exclusive Licensing and Supply Deal for the Commercialization of Liraglutide in South Korea with Handok Inc	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Biocon Ties Up with Handok to Market Anti-Diabetic Drug Liraglutide in South Korea	24/05	MT
Biocon Limited Signs Exclusive Licensing and Supply Deal for the Commercialization of Liraglutide in South Korea with Handok Inc	24/05	CI
Nxera Pharma Partners with Handok c. to Distribute PIVLAZ in South Korea,	16/04	MT
Nxera Pharma Announces Exclusive Supply and Distribution Agreement with Handok for Pivlaz in South Korea	15/04	CI
Sobi and Handok establish joint venture for rare disease business in South Korea	14/02	AQ
Sobi to Expand in South Korea via Rare Disease JV with Handok	13/02	MT
HANDOK Inc.(KOSE:A002390) dropped from S&P Global BMI Index	18/23/18	CI
HANDOK Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Rezolute Unveils Plans for Secondary Offering of 3.24 Million Shares	29/22/29	MT
I-Mab Completes Enrollment in China Phase 3 Trial of Eftansomatropin Alfa in Pediatric Growth Hormone Deficiency	14/22/14	MT
AUM Biosciences Enters in A Strategic Collaboration with Handok and CMG Pharm to Develop ‘CHC2014’, New Pan-TRK Inhibitor for Cancer Treatment	11/21/11	CI
WELT Corp., Ltd announced that it has received KRW 6 billion in funding from HANDOK Inc., Smilegate Investment, Inc., POSCO Venture Capital Co., Ltd.	25/21/25	CI
Adicet Bio, Inc. announced that it has received $80 million in funding from a group of investors	02/19/02	CI
Rezolute, Inc. announced that it has received $24.05 million in funding from Genexine, Inc., Handok, Inc., District 2 Capital Fund LP, The Bigger Capital Fund, LP and another investor	12/19/12	CI
Adicet Bio, Inc. announced that it expects to receive $80 million in funding	25/19/25	CI
Rezolute, Inc. announced that it expects to receive $20.25 million in funding from District 2 Capital Fund LP, The Bigger Capital Fund, LP, Genexine, Inc., Handok, Inc.	23/19/23	CI
TRIGR Therapeutics, Inc announced that it has received $14 million in funding from Handok Inc.	25/19/25	CI
BiomX Ltd announced that it has received $32 million in funding from a group of investors	20/19/20	CI
Rezolute, Inc. announced that it has received $25 million in funding from Genexine, Inc., Handok, Inc.	30/19/30	CI
Rezolute, Inc. announced that it expects to receive $25 million in funding from Genexine, Inc., Handok Inc.	07/19/07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News HANDOK Inc.

Equities

A002390

KR7002390003

All News

Filters